{'fraction_non_alphanumeric': 0.021321961620469083, 'fraction_numerical': 0.005330490405117271, 'mean_word_length': 5.137254901960785, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Cardiac troponin I in chronic hemodialysis. Comparison of methods and results after 3 months].

The laboratory and instrumental markers today in use for the determination of myocardial damage present limitations in dialysis patients due to interference patterns that tend to reduce prognostic evaluation. The aim of this study is to evaluate whether troponin I (cTnI), a recently established marker of myocardial damage, can help to identify, in asymptomatic patients too, minor ischemic lesions that could screen this patient population for future acute cardiac events. In our study of 103 patients undergoing chronic dialysis, instrumental measurements and serum dosages of cTnI were carried out at the onset and after three months, using first and second generation methods. Among the patients who tested positive using the above tests, 4 acute cardiac events were observed. A follow-up of the present study is due in one year's time.